Comparison of the efficacy of intravenous sodium valproate and acetaminophen in attacks of headaches

Comparison of the efficacy of intravenous sodium valproate and acetaminophen(paracetamol) in attacks of headaches

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141209020258N102

Enrollment

Registered

2019-04-07

Start date

2019-01-21

Completion date

Unknown

Last updated

2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine headach. Migraine

Interventions

Intervention 1: Intervention group: In the first group, we inject valproate 400 milligram intravenously and infused slowly. Intervention 2: Intervention group: In second group we inject ampule of acet

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Normal systemic and neurological examinations 20 to 50 yeras

Exclusion criteria

Exclusion criteria: Allergy to acetaminophen Hyperammonium Lack of cooperation

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: One and six hours after the start of the study. Method of measurement: Visual analog scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Behzadi nia

Arak University of Medical Sciences

behzaninia@arakmu.ac.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026